Jiaxin Zhou Selected Research

Jiaxin Zhou Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 10/2019
10	Immunoglobulin G4-Related Disease 01/2022 - 11/2015
7	Infections 01/2022 - 03/2017
3	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 04/2021
3	Lung Neoplasms (Lung Cancer) 08/2021 - 11/2020
3	Autoimmune Diseases (Autoimmune Disease) 06/2021 - 10/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2019
3	Neutropenia 01/2020 - 03/2017
3	Inflammation (Inflammations) 10/2019 - 03/2017
2	Hypersensitivity (Allergy) 12/2021 - 03/2017
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2021 - 01/2021
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 10/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 10/2019
2	Cytopenia 01/2020 - 10/2019
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 10/2019
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020 - 10/2019
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 10/2019
2	Pancytopenia 01/2020 - 10/2019
2	Pneumonia (Pneumonitis) 01/2020 - 10/2019
1	Neuroinflammatory Diseases 06/2022
1	Autoimmune Pancreatitis 06/2022
1	Atrophy 06/2022
1	Substance-Related Disorders (Drug Abuse) 04/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Carcinogenesis 01/2022
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2022
1	Sialadenitis 12/2021
1	Behcet Syndrome (Behcet's Syndrome) 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021
1	Rheumatic Diseases (Rheumatism) 12/2021
1	Pulmonary Arterial Hypertension 11/2021
1	Left Ventricular Dysfunction 11/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021
1	Systemic Scleroderma (Systemic Sclerosis) 11/2021
1	Fibrosis (Cirrhosis) 11/2021
1	COVID-19 05/2021
1	Cryoglobulinemia 01/2021
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021
1	Lung Injury 11/2020
1	Intestinal Polyposis (Polyposis, Intestinal) 09/2020
1	Pericardial Effusion 08/2020

Drug/Important Bio-Agent (IBA)

20	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
6	GlucocorticoidsIBA 06/2022 - 11/2015
6	Immunoglobulin G (IgG)IBA 06/2022 - 08/2019
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2021
3	Neutralizing AntibodiesIBA 01/2022 - 05/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	LigandsIBA 01/2022 - 01/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 11/2015
2	AutoantibodiesIBA 01/2022 - 06/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2019
2	Monoclonal AntibodiesIBA 01/2022 - 10/2019
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	Biological ProductsIBA 12/2021 - 01/2021
2	AntibodiesIBA 05/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	Immunoglobulin E (IgE)IBA 01/2021 - 10/2020
2	C-Reactive ProteinIBA 01/2021 - 03/2017
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Inosine Triphosphate (ITP)IBA 01/2020 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 10/2019
2	EnzymesIBA 01/2018 - 03/2017
1	SynaptophysinIBA 06/2022
1	Adenosine Triphosphate (ATP)IBA 06/2022
1	Interleukin-9 (Interleukin 9)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	AgarIBA 01/2022
1	CarcinogensIBA 01/2022
1	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 12/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Uric Acid (Urate)IBA 11/2021
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	CollagenIBA 11/2021
1	Long Noncoding RNAIBA 08/2021
1	mRNA VaccinesIBA 05/2021
1	Inactivated VaccinesIBA 05/2021
1	Protein Isoforms (Isoforms)IBA 04/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	tofacitinibIBA 01/2021
1	Cytochromes c (Cytochrome c)IBA 01/2021
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2021
1	LysophospholipidsIBA 01/2021
1	Clemastine (Clemastine Fumarate)FDA LinkGeneric 01/2021
1	glyceric acidIBA 01/2021
1	Uridine Triphosphate (UTP)IBA 01/2021
1	Linoleic Acid (Linoleate)IBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	Uridine Diphosphate Galactose (UDP Galactose)IBA 01/2021
1	CeramidesIBA 01/2021
1	Particulate MatterIBA 11/2020

Therapy/Procedure

13	Therapeutics 06/2022 - 03/2017
5	Immunotherapy 01/2022 - 10/2019
2	Aftercare (After-Treatment) 06/2022 - 08/2019
1	Anesthesia 01/2021
1	Lasers (Laser) 09/2020